KOKO Medical Announces Headquarters Relocation to Hankin Group’s Eagleview in Exton, PA
The medical equipment manufacturing company leases more than 19,000 square feet at 770 Pennsylvania Drive
EXTON, PA (September 10, 2024) – Hankin Group, a vertically integrated real estate company, has announced that KOKO Medical Inc., a medical device and women’s health company, has moved its corporate headquarters to 770 Pennsylvania Drive at Eagleview in Exton, PA. The 19,859 square foot space is an expansion for the Malvern-based startup, which is committed to saving the lives of mothers through innovative medical products.
The relocation and expansion are a critical step in KOKO Medical’s business trajectory, as the startup prepares to transition from development into commercial manufacturing. The organization is an early-stage catheter-based technology to treat postpartum hemorrhage, which is experienced by more than 10% of women during childbirth and can lead to death and other severe complications.
“We are committed to bringing the highest quality, safest product to market in order to save the lives of countless mothers, and we needed a purpose built, medical manufacturing facility that could be tailored to meet the needs of our business,” said Jason Keiser, co-founder and vice president of operations, KOKO Medical Inc. “Between the state-of-the-art facility, on-site amenities, and superior property management, Eagleview was an ideal option for our next phase.”
“We are thrilled to officially welcome KOKO Medical into their brand-new headquarters at Eagleview, a burgeoning hub for the life sciences sector,” said Bob Hankin, CEO, Hankin Group. “We are confident Eagleview will be an excellent new home for KOKO Medical during an exciting chapter of innovation and growth for the company.”
770 Pennsylvania Drive is a fully leased 63,000 square foot flex building designed for office, research & development, pharmaceutical, light manufacturing and assembly, and warehouse uses. The addition of KOKO Medical signals the continued growth of the life sciences industry in the Greater Philadelphia region.
Hankin Group also recently announced the addition of Frontage Laboratories, a full spectrum CDMO, and Fruh Packaging, a Swiss pharmaceutical packaging company, at 240 Sierra Drive at Eagleview. In addition to 240 Sierra Drive, Hankin Group has delivered one million square feet of life sciences, research, and development space in Eagleview, with tenants including West Pharmaceutical Services, Takeda Pharmaceuticals, Castle Biosciences, DSM, Immunome, and more.
Eagleview is an award-winning, 800-acre mixed-use community located in Chester County, PA. The master planned community boasts over 1,000 residences, 2.5 million square feet of distinctive commercial office space, and over 50,000 square feet of prime retail space. Eagleview’s thoughtfully designed system of sidewalks, jogging paths, and greenways create a unique experience that seamlessly integrates the residential, commercial, and retail aspects of the community.
KOKO Medical was represented by Mitch Reading of Tactix Real Estate Advisors. Hankin Group was represented internally by Sam Sherrill.
For additional information on Eagleview, visit www.hankingroup.com/eagleview.
Frontage Laboratories Expands to Occupy 200,000 SF of Life Sciences Space at Hankin Group’s Eagleview in Exton, PA
Frontage Laboratories joins Fruh Packaging at 240 Sierra Drive; the life sciences building is now 100% occupied
EXTON, PA (August 14, 2024) – Hankin Group, a vertically integrated real estate company, has announced that Frontage Laboratories, a full spectrum Contract Development and Manufacturing Organization (CDMO), has occupied an additional 46,300 square feet of life sciences space at 240 Sierra Drive at Eagleview in Exton, PA. The organization will use the new space at Eagleview for their CMC-Product Development & Manufacturing service line.
Frontage Labs joins Fruh Packaging to bring occupancy of the brand new 113,000 square foot GMP life sciences building to 100%. The two companies bring hundreds of jobs to Chester County and represent the continued growth of the life sciences industry in the Greater Philadelphia region.
Frontage Labs, a pharmaceutical development company headquartered in Exton, PA, already occupies over 150,000 square feet of life science space in Eagleview, bringing the company’s Exton, PA total footprint to more than 200,000 square feet. It is estimated that Frontage Lab’s CMC Expansion Project will open 100 new employment opportunities in the Exton area.
Fruh Packaging, a Swiss pharmaceutical packaging company, occupied 240 Sierra Drive in February 2024 after an extensive search, ultimately selecting Eagleview as the company’s first American headquarters.
“Eagleview, with its robust infrastructure and unique live, work, play environment, is particularly well suited for life sciences companies,” said Sam Sherrill, Commercial Sales and Leasing Manager, Hankin Group. “Our master planned community offers more than 575,000 square feet of research and development space, quality residential and retail opportunities, and easy access to a highly skilled workforce, making it a perfect hub for growth and collaboration in the life sciences sector.”
“Expanding our CDMO operations at Eagleview was a strategic, and logical, next step for our business. The Hankin team knows how to develop life science properties, and their property management team ensures our operations run seamlessly,” said Dr. Song Li, Executive Chairman, Frontage Labs. “Eagleview is a place that we can continue to grow for years to come.”
Eagleview is an award-winning, 800-acre mixed-use community located in Chester County, PA. The master planned community boasts over 1,000 residences, 2.5 million square feet of distinctive commercial office space, and over 50,000 square feet of prime retail space. Eagleview’s thoughtfully designed system of sidewalks, jogging paths, and greenways create a unique experience that seamlessly integrates the residential, commercial, and retail aspects of the community.
In addition to 240 Sierra Drive, Hankin Group has delivered 1 million square feet of life sciences and research and development space in Eagleview, with tenants including West Pharmaceutical, Takeda Pharmaceuticals, Castle Biosciences, DSM, and Immunome, among others.
About Hankin Group
Located in Exton, Pennsylvania, Hankin Group (Hankin) is a full-service, family-owned real estate company who designs, develops, and manages residential and commercial properties. For more information about Hankin Group and its projects, please visit www.hankingroup.com.
About Eagleview
Eagleview is an 800-acre, award-winning mixed-use community, masterfully developed by Hankin Group. This meticulously planned community features over 1,000 residences, 2.5 million square feet of distinctive commercial office space, and over 50,000 square feet of prime retail space. Eagleview is designed with an extensive network of sidewalks, jogging paths, and greenways that seamlessly connect homes, markets, and workplaces.
At the heart of Eagleview lies Eagleview Town Center, a vibrant hub complete with Restaurant Row, specialty shops, a salon and spa, professional offices, a state-of-the-art fitness center, and a highly accredited daycare. The Town Center also boasts a beautifully landscaped two-acre gathering that hosts community events, including festivals, movie nights, summer concerts, and a weekly farmer’s market.
About Frontage
Frontage Holdings Corp (1521.HK), together with its wholly owned subsidiary Frontage Laboratories, Inc., is a global Contract Development and Manufacturing Organization (CDMO) which provides integrated, science-driven, product development services from drug discovery to late phase clinical process to enable biopharmaceutical companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, novel drug delivery, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of new molecules through development and to successfully file global regulatory submissions. For more details visit: www.frontagelab.com.
Hankin Group Breaks Ground on Haywood Business Park Expansion in Exton, PA
New 70,000 square foot speculative business park offers prime location near Route 100, I-76, and PA Turnpike
EXTON, PA (July 24, 2024) – Hankin Group, a vertically integrated real estate company, has begun construction on Haywood Business Park’s next phase along Haywood Drive in Chester County, Pennsylvania. The site will stagger delivery of two, 35,000 square foot flex/industrial speculative buildings designed for light manufacturing and assembly, warehouse, or research and development uses.
Hankin has begun leasing for the first building located at 713 Haywood Drive. The 35,000 square foot building will be built to the following specifications: 140’ x 250’ dimensions, 20’ clear height, 45’ column spacing, 277/480V 3Phase 600 AMP electric, ESFR sprinkler system, and four dock doors with over 10 knockout panels for expansion. Fifty-four parking spaces will be available along the front of the building.
Situated in the heart of Philadelphia’s northwest suburbs, Haywood Business Park is in a premier location just north of the Route 100 and 1-76 intersection, 0.25 miles from the PA Turnpike, and about 40 miles from Center City Philadelphia, Philadelphia International Airport, and The Port of Philadelphia (PhilaPort). The population within a 90-minute drive to Haywood Business Park is 10.1 million and a 1.3 million workforce is within a 45-minute drive.
“Haywood Business Park offers future tenants direct access to key commercial routes, the region’s best amenities, and a booming workforce,” said Bob Hankin, President and CEO, Hankin Group. “With its prime location, ability to tailor tenant’s fit out, and Hankin’s commitment to unparalleled property management, 713 Haywood Drive is the perfect opportunity for industrial and commercial businesses looking to grow.”
The space is also across from Hankin Group’s award-winning Eagleview, an amenity-rich, 800-acre mixed-use community in Chester County, PA. The master planned community boasts over 1,000 residences, 2.5 million square feet of distinctive commercial office and life science space, and over 50,000 square feet of prime retail space. Eagleview’s thoughtfully designed system of sidewalks, jogging paths, and greenways create a unique experience that seamlessly integrates the residential, commercial, and retail aspects of the community.
Construction on 713 Haywood is slated to be completed in Q1 2025. For leasing information, please call Stacy Martin and Sam Sherrill at (610) 458-1900 x3 or email them at commercialleasing@hankingroup.com.
HANKIN GROUP CUTS THE RIBBON FOR HANKIN MANOR WITH COMMUNITY LEADERS IN PHOENIXVILLE
Hankin Manor is the latest affordable senior housing development to open in the booming borough
PHOENIXVILLE, PA: Yesterday, Hankin Group, a leading real estate developer, celebrated the grand opening of Hankin Manor, a state-of-the-art, affordable, senior housing community in the heart of Phoenixville Borough, at a ribbon cutting ceremony with community leaders and instrumental partners. Hankin Manor sits on the site of the former Borough maintenance facility and residents have already begun moving in, with the community expected to fill quickly.
“Hankin Manor is a testament to the forward thinking of the Phoenixville Borough. They had identified a need in their community and a property in need of repurposing. We were tapped to do what we do best, come up with an elegant solution that helps lift the community. We believe we’ve accomplished that with the design of Hankin Manor and will continue to support the community with our award-winning property management team at Hankin Apartments,” said Bob Hankin, CEO of Hankin Group.
The grand opening was marked with words of enthusiasm and support from Robin Wiessmann, Executive Director and CEO of PA Housing Finance Agency, Peter Urscheler, Mayor of Phoenixville, Jonathan Ewald, Phoenixville Borough Council President, and Chester County Commissioners, Marian Moskowitz, Josh Maxwell, and Eric Roe, and Hankin Group CEO, Bob Hankin.
“Phoenixville has seen tremendous growth which has been reflected in rising housing prices. We knew we had to act quickly to prevent our elders from being priced out of the community they call home,” said Jon Ewald, Phoenixville Borough Council President. “Hankin Group has tremendous experience creating value for the communities in which they develop, they were the ideal partner for this project vital to the fabric of Phoenixville.”
“Our senior citizens are a treasure of the Phoenixville community, and we want to ensure they have a dignified place to call home to enjoy their golden years,” said Peter Urscheler, Mayor of Phoenixville Borough. “It was a pleasure working with Hankin Group as they understood our vision and mission to turn this derelict property into a jewel for our community. They delivered on our promise.”
Hankin Manor, located at 115 Buchanan Street, represents a significant milestone in addressing the pressing need for affordable senior housing in the region. This 50-unit apartment community, managed by Hankin Apartments, is poised to provide comfortable and modern living spaces for its senior residents, contributing to the vibrancy and inclusivity of the Phoenixville community.
Attendees had the chance to tour the community and enjoy light refreshments, symbolizing the spirit of collaboration and community engagement underpinning the Hankin Manor project.
For more information about Hankin Manor or to apply for an apartment please visit hankinmanor.com or call 484-996-3880.
Hankin Manor represents a collaborative effort between Hankin Group, Phoenixville Borough, Pennsylvania Housing Finance Agency, Chester County Department of Community Development, Key Bank, and Phoenixville Federal Bank & Trust.
Architects on the project were UpStreet Architects and NORR, structural engineering by NORR, MEP engineering by East Hills Engineering, civil engineering by Cedarville Engineering Group, and construction by Hankin Construction.